查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1362865

人類生長激素市場規模、佔有率、趨勢分析報告：按配銷通路、按用途、按產品、按地區、細分市場趨勢，2023-2030

Human Growth Hormone Market Size, Share & Trends Analysis Report By Distribution Channel (Hospital Pharmacy, Retail Pharmacy), By Application, By Product, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 129 Pages | 商品交期: 2-10個工作天內

價格

人類生長激素市場成長與趨勢

Grand View Research, Inc.最新報告顯示，預計2030年全球人類生長激素市場規模將達到142.8億美元，2023年至2030年年複合成長率為12.3%。

由於生長激素缺乏症和其他生長相關疾病的日益罹患率，市場正在見證成長。致力於開發創新且具有成本效益的治療方案的主要企業之間的激烈競爭也推動了市場的成長。父母對兒童生長的日益關注導致對人類生長激素 (HGH) 治療的需求增加。 《今日加拿大》的一份報告強調，父母對兒童的身高表現出特別的興趣，並願意投資侏儒症的治療方案。

同樣，在中國，即使沒有醫學異常，兒童對 HGH 治療的需求也很高。人們對兒童正常發育的日益關注正在為行業相關人員創造新的機會。在該地區公眾醫療保健意識不斷提高、重要的政府舉措和有利的報銷政策的推動下，北美地區預計將經歷快速成長。此外，活性化研發活動、確保充足的研究資金以及積極宣傳和治療方法方案的組織的存在預計將推動該地區的市場成長。

此外，北美市場擁有輝瑞（Pfizer）和禮來（Lilly）等主要企業的大量業務，為全球市場的高盈利收益佔有率做出了重大貢獻。越來越多的法規核准和創新 HGH治療方法的推出也有助於市場擴張。例如，2022 年 1 月，輝瑞公司和 OPKO Health, Inc. 獲得美國食品藥物管理局(FDA) 的給藥，推出先進的每週一次的長效生長激素注射液，用於治療生長激素缺乏症。我們已獲得藥物NGENLA 的上市核准。 NGENLA 預計將於 2023 年 8 月開始在美國上市。

同樣，2021年8月，美國FDA核准了Ascengis Pharma推出的lonapeg somatropin-tcgd (SKYTROFA)，用於治療兒童患者的生長停滯。這些法規的核准和新 HGH 治療方案的推出有助於市場擴張並促進該領域的進一步發展。由於大眾對生長激素缺乏症及其治療方法的認知不斷提高，以及對早期診斷的重視，北美在 2022 年佔據了最大的銷售佔有率。由於領先公司的投資增加和學名藥的快速採用，預計亞太地區在預測期內將呈現最快的年複合成長率。

印度和中國人口眾多，預計將為醫療保健領域的發展提供巨大機會。因此，製藥公司，包括專門生產 HGH 藥物的製藥公司，正在這些國家進行大量投資。輝瑞、諾華、默克和梯瓦製藥公司主導全球市場。這些公司正在採取新產品開發、併購、聯盟等策略來擴大市場佔有率。 2023 年 6 月，全球健康與健身產業的領導者 Domestic Supply 推出了經過科學檢驗的HGH 補充品。這項創新產品代表了性能增強和整體健康領域的顯著進步，為世界各地意願健康的人們提供了更高的生活品質。

人類生長激素市場報告亮點

  • 從按產品來看，包括短效生長激素在內的其他細分市場將在 2022 年佔據市場主導地位。越來越多的法規核准短效 GH 療法以及該領域持續的研發活動正在促進市場成長。
  • 由於對人類生長激素缺乏症治療和早期診斷的高度認知，加上全球市場上新藥的推出，生長激素缺乏症用途領域在 2022 年佔據市場主導地位。
  • 根據最終用途，由於人們對生長激素缺乏症及其治療功效的認知不斷提高，醫院就診次數增加，醫院藥房領域將在 2022 年佔據主導地位。
  • 重組 DNA 技術在眾多藥品的設計和製造中發揮著重要作用，特別是那些用於患有生長激素缺乏症的成人和兒童的生長激素替代療法的藥品。
  • 預計該市場將在 2022 年成為第二大測試領域，家庭 A1C 測試領域的收益將增加。

目錄

第1章 調查方法與範圍

第2章 執行摘要

第3章 市場變數、趨勢和範圍

  • 市場體系預測
    • 母市場預測
    • 相關/附隨市場預測
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 產業分析工具
    • 波特五力分析
    • PESTEL分析
    • COVID-19 影響分析

第4章 產品經營分析

  • 人類生長激素市場：產品波動分析
  • 長效
    • 長期市場，2018-2030
  • 其他
    • 其他市場，2018-2030

第5章 應用業務分析

  • 人類生長激素市場：應用變化分析
  • 生長激素缺乏症
  • 特納氏症候群
  • 原發性矮小症
  • 普瑞德威利症候群
  • 小於胎齡
  • 其他

第6章 配銷通路業務分析

  • 人類生長激素市場：配銷通路波動分析
  • 醫院藥房
    • 醫院藥局市場，2018-2030
  • 零售藥房
    • 零售藥局市場，2018-2030
  • 網路藥房
    • 2018-2030年網路藥局市場
  • 專業藥房
    • 專業藥局市場，2018-2030

第7章 區域業務分析

  • 2022 年及 2030 年人類生長激素市場佔有率（按地區）
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第8章 競爭形勢

  • 公司分類
  • 策略規劃
  • 2022 年公司市場佔有率分析
  • 公司簡介/名單
    • Novo Nordisk A/S
    • Pfizer, Inc
    • Eli Lilly and Company
    • Sandoz International GmbH（Novartis AG）
    • Merck KGaA
    • Genentech, Inc（Roche）
    • Ferring Pharmaceuticals
    • Teva Pharmaceutical Industries, Ltd
    • Ipsen
Product Code: GVR-2-68038-057-6

Human Growth Hormone Market Growth & Trends:

The global human growth hormone market size is expected to reach USD 14.28 billion by 2030, growing at a CAGR of 12.3% from 2023 to 2030, according to a new report by Grand View Research, Inc.. The market is witnessing growth due to an increase in the incidence of growth hormone deficiency and other growth-related disorders. In addition, market growth is being driven by intense competition among key players striving to develop innovative and cost-effective treatment options. The increasing parental concerns regarding the growth of their children are contributing to the rising demand for human growth hormone (HGH) therapy. Reports from Canada Today highlight that parents are showing particular concern about the height of their children and are willing to invest in treatment options for dwarfism.

Similarly, in China, there is a high demand for HGH treatment for children, even in the absence of any medical abnormality. These growing concerns about the normal development of children have opened up new opportunities for industry players. North America is projected to experience rapid growth driven by increasing healthcare awareness among the population, significant government initiatives, and favorable reimbursement policies in the region. Furthermore, a rise in research & development activities, the availability of sufficient research funding, and the presence of organizations that actively promote awareness & treatment options are expected to drive the regional market growth.

In addition, the North America market benefits from the strong presence of top industry players, including Pfizer Inc. and Lilly, which significantly contributes to its profitable revenue share in the global industry. The increasing number of regulatory approvals and the introduction of innovative HGH treatment regimens are also contributing to the market expansion. For instance, in January 2022, Pfizer, Inc. and OPKO Health, Inc. obtained approval from the U.S. Food and Drug Administration (FDA) for NGENLA's commercialization, an advanced long-acting growth hormone injection with a once-a-week dosage for treating growth hormone deficiency in the country. NGENLA is anticipated to be available for prescription in the United States starting from August 2023.

Similarly, in August 2021, the U.S. FDA approved lonapegsomatropin-tcgd (SKYTROFA) introduced by Ascendis Pharma, for the treatment of development stoppage in pediatric patients. These regulatory approvals and the launch of novel HGH regimens are contributing to the market's expansion and driving further advancements in the field. North America held the largest revenue share in 2022 due to a rise in awareness among people about growth hormone deficiency and its treatments, along with an emphasis on early diagnosis. Asia Pacific is expected to exhibit the fastest CAGR over the forecast period due to the rising investments by leading players and the surge in generic adoption in the region.

India and China are anticipated to offer significant opportunities for the advancement of the healthcare sector, driven by their large population. Consequently, pharmaceutical companies, including those specializing in HGH drugs, are making substantial investments in these countries. Pfizer Inc., Novartis AG, Merck & Co., Inc., and Teva Pharmaceutical Industries Ltd. dominate the global market. These companies adopt strategies, such as new product development, merger & acquisition, and partnership, to increase their market share. In June 2023, the global health and fitness industry leader, Domestic Supply, launched a scientifically validated HGH supplement. This novel product marks a remarkable advancement in the field of performance enhancement and overall well-being, offering health-conscious individuals worldwide an enhanced quality of life

Human Growth Hormone Market Report Highlights:

  • Based on product, the others segment including the short-acting growth hormone dominated the market in 2022. Increased approvals by regulatory authorities for short-acting GH therapies, along with ongoing R&D activities in this field, contribute to the growth of the market
  • The growth hormone deficiency application segment dominated the market in 2022 due to the high awareness levels about the treatment of growth hormone deficiency and early diagnosis in humans, coupled with the introduction of new drugs in the global market
  • Based on the end-use, the hospital pharmacy segment dominated the market in 2022 due to the increased number of hospital visits driven by rising awareness about growth hormone deficiency and the effectiveness of its treatments
  • Recombinant DNA technology plays a crucial role in designing and manufacturing numerous drugs, particularly those used for growth hormone replacement treatment in both adults and children who suffer from growth hormone deficiency
  • The market is expected to witness increased revenue generation in the at-home A1C testing segment, positioning it as the second-largest testing segment in 2022, primarily driven by higher adoption rates

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Application segment
      • 1.1.1.2. Product segment
      • 1.1.1.3. Distribution channel segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Objectives
    • 1.4.1. Objective - 1
    • 1.4.2. Objective - 2
    • 1.4.3. Objective - 3
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary research
  • 1.7. Information or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List of Secondary Sources
  • 1.11. List of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Application and Product Snapshot
  • 2.3. Distribution Channel Snapshot
  • 2.4. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing prevalence of human growth hormone
      • 3.2.1.2. Growing investments and governmental funding in the development of diagnostics
      • 3.2.1.3. Growing awareness of human growth hormone
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Shift of funds to tackle other diseases in low health budgets.
      • 3.2.2.2. Shortage of funding from international partners and foreign government
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Product Business Analysis

  • 4.1. Human Growth Hormone Market: Product Movement Analysis
  • 4.2. Long Acting
    • 4.2.1. Long Acting Market, 2018 - 2030 (USD Million)
  • 4.3. Others
    • 4.3.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Application Business Analysis

  • 5.1. Human Growth Hormone Market: Application Movement Analysis
  • 5.2. Growth Hormone Deficiency
    • 5.2.1. Growth Hormone Deficiency Market, 2018 - 2030 (USD Million)
    • 5.2.2. Adult Growth Hormone Deficiency
      • 5.2.2.1. Adult Growth Hormone Deficiency Market, 2018 - 2030 (USD Million)
    • 5.2.3. Pediatric Growth Hormone Deficiency
      • 5.2.3.1. Pediatric Growth Hormone Deficiency Market, 2018 - 2030 (USD Million)
  • 5.3. Turner Syndrome
    • 5.3.1. Turner Syndrome Market, 2018 - 2030 (USD Million)
  • 5.4. Idiopathic Short Stature
    • 5.4.1. Idiopathic Short Stature Market, 2018 - 2030 (USD Million)
  • 5.5. Prader-Willi Syndrome
    • 5.5.1. Prader-Willi Syndrome Market, 2018 - 2030 (USD Million)
  • 5.6. Small for Gestational Age
    • 5.6.1. Small for Gestational Age Market, 2018 - 2030 (USD Million)
  • 5.7. Other
    • 5.7.1. Other Market, 2018 - 2030 (USD Million)

Chapter 6. Distribution Channel Business Analysis

  • 6.1. Human Growth Hormone Market: Distribution Channel Movement Analysis
  • 6.2. Hospital Pharmacy
    • 6.2.1. Hospital Pharmacy Market, 2018 - 2030 (USD Million)
  • 6.3. Retail Pharmacy
    • 6.3.1. Retail Pharmacy Market, 2018 - 2030 (USD Million)
  • 6.4. Online Pharmacy
    • 6.4.1. Online Pharmacy Market, 2018 - 2030 (USD Million)
  • 6.5. Specialty Pharmacy
    • 6.5.1. Specialty Pharmacy Market, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis

  • 7.1. Human Growth Hormone Market Share By Region, 2022 & 2030
  • 7.2. North America
    • 7.2.1. SWOT Analysis
    • 7.2.2. North America Human Growth Hormone Market, 2018 - 2030 (USD Million)
    • 7.2.3. U.S.
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. Competitive Scenario
      • 7.2.3.3. Regulatory Framework
      • 7.2.3.4. U.S. Human Growth Hormone Market, 2018 - 2030 (USD Million)
    • 7.2.4. Canada
      • 7.2.4.1. Key Country Dynamics
      • 7.2.4.2. Competitive Scenario
      • 7.2.4.3. Regulatory Framework
      • 7.2.4.4. Canada Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. SWOT Analysis
    • 7.3.2. Europe Human Growth Hormone Market, 2018 - 2030 (USD Million)
    • 7.3.3. UK
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Regulatory Framework
      • 7.3.3.4. UK Human Growth Hormone Market, 2018 - 2030 (USD Million)
    • 7.3.4. Germany
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Regulatory Framework
      • 7.3.4.4. Germany Human Growth Hormone Market, 2018 - 2030 (USD Million)
    • 7.3.5. France
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. Competitive Scenario
      • 7.3.5.3. Regulatory Framework
      • 7.3.5.4. France Human Growth Hormone Market, 2018 - 2030 (USD Million)
    • 7.3.6. Italy
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Competitive Scenario
      • 7.3.6.3. Regulatory Framework
      • 7.3.6.4. Italy Human Growth Hormone Market, 2018 - 2030 (USD Million)
    • 7.3.7. Spain
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Competitive Scenario
      • 7.3.7.3. Regulatory Framework
      • 7.3.7.4. Spain Human Growth Hormone Market, 2018 - 2030 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Key Country Dynamics
      • 7.3.8.2. Competitive Scenario
      • 7.3.8.3. Regulatory Framework
      • 7.3.8.4. Sweden Human Growth Hormone Market, 2018 - 2030 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Key Country Dynamics
      • 7.3.9.2. Competitive Scenario
      • 7.3.9.3. Regulatory Framework
      • 7.3.9.4. Norway Human Growth Hormone Market, 2018 - 2030 (USD Million)
    • 7.3.10. Denmark
      • 7.3.10.1. Key Country Dynamics
      • 7.3.10.2. Competitive Scenario
      • 7.3.10.3. Regulatory Framework
      • 7.3.10.4. Denmark Human Growth Hormone Market, 2018 - 2030 (USD Million)
    • 7.3.11. Russia
      • 7.3.11.1. Key Country Dynamics
      • 7.3.11.2. Competitive Scenario
      • 7.3.11.3. Regulatory Framework
      • 7.3.11.4. Russia Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. SWOT Analysis
    • 7.4.2. Asia Pacific Human Growth Hormone Market, 2018 - 2030 (USD Million)
    • 7.4.3. Japan
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Japan Human Growth Hormone Market, 2018 - 2030 (USD Million)
    • 7.4.4. China
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. China Human Growth Hormone Market, 2018 - 2030 (USD Million)
    • 7.4.5. India
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Regulatory Framework
      • 7.4.5.4. India Human Growth Hormone Market, 2018 - 2030 (USD Million)
    • 7.4.6. Australia
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Regulatory Framework
      • 7.4.6.4. Australia Human Growth Hormone Market, 2018 - 2030 (USD Million)
    • 7.4.7. Thailand
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Regulatory Framework
      • 7.4.7.4. Thailand Human Growth Hormone Market, 2018 - 2030 (USD Million)
    • 7.4.8. South Korea
      • 7.4.8.1. Key Country Dynamics
      • 7.4.8.2. Competitive Scenario
      • 7.4.8.3. Regulatory Framework
      • 7.4.8.4. South Korea Human Growth Hormone Market, 2018 - 2030 (USD Million)
    • 7.4.9. Singapore
      • 7.4.9.1. Key Country Dynamics
      • 7.4.9.2. Competitive Scenario
      • 7.4.9.3. Regulatory Framework
      • 7.4.9.4. Indonesia Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. SWOT Analysis
    • 7.5.2. Latin America Human Growth Hormone Market, 2018 - 2030 (USD Million)
    • 7.5.3. Brazil
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Brazil Human Growth Hormone Market, 2018 - 2030 (USD Million)
    • 7.5.4. Mexico
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. Mexico Human Growth Hormone Market, 2018 - 2030 (USD Million)
    • 7.5.5. Argentina
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competitive Scenario
      • 7.5.5.3. Regulatory Framework
      • 7.5.5.4. Argentina Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • 7.6. MEA
    • 7.6.1. SWOT Analysis
    • 7.6.2. MEA Human Growth Hormone Market, 2018 - 2030 (USD Million)
    • 7.6.3. South Africa
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. South Africa Human Growth Hormone Market, 2018 - 2030 (USD Million)
    • 7.6.4. Saudi Arabia
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Saudi Arabia Human Growth Hormone Market, 2018 - 2030 (USD Million)
    • 7.6.5. UAE
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. UAE Human Growth Hormone Market, 2018 - 2030 (USD Million)
    • 7.6.6. Kuwait
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Competitive Scenario
      • 7.6.6.3. Regulatory Framework
      • 7.6.6.4. Kuwait Human Growth Hormone Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Share Analysis, 2022
  • 8.4. Company Profiles/Listing
    • 8.4.1. Novo Nordisk A/S
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. Pfizer, Inc
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. Eli Lilly and Company
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Sandoz International GmbH (Novartis AG)
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Merck KGaA
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. Genentech, Inc (Roche)
      • 8.4.6.1. Overview
      • 8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. Ferring Pharmaceuticals
      • 8.4.7.1. Overview
      • 8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. Teva Pharmaceutical Industries, Ltd
      • 8.4.8.1. Overview
      • 8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. Ipsen
      • 8.4.9.1. Overview
      • 8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Human Growth Hormone Market, By Region, 2018 - 2030 (USD Million)
  • Table 4 Global Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 5 Global Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 6 Global Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 7 North America Human Growth Hormone Market, By Country, 2018 - 2030 (USD Million)
  • Table 8 North America Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 9 North America Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 10 North America Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 11 U.S. Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 12 U.S. Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 13 U.S. Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 14 Canada Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 15 Canada Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 16 Canada Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 17 Europe Human Growth Hormone Market, By Country, 2018 - 2030 (USD Million)
  • Table 18 Europe Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 19 Europe Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 20 Europe Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 21 UK Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 22 UK Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 23 UK Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 24 Germany Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 25 Germany Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 26 Germany Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 27 France Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 28 France Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 29 France Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 30 Italy Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 31 Italy Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 32 Italy Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 33 Spain Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 34 Spain Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 35 Spain Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 36 Russia Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 37 Russia Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 38 Russia Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 39 Denmark Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 40 Denmark Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 41 Denmark Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 42 Sweden Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 43 Sweden Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 44 Sweden Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 45 Norway Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 46 Norway Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 47 Norway Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Human Growth Hormone Market, By Country, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 51 Asia Pacific Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 52 China Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 53 China Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 54 China Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 55 India Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 56 India Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 57 India Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 58 South Korea Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 59 South Korea Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 60 South Korea Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 61 Japan Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 62 Japan Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 63 Japan Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 64 Singapore Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 65 Singapore Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 66 Singapore Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 67 Australia Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 68 Australia Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 69 Australia Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 70 Thailand Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 71 Thailand Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 72 Thailand Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 73 Latin America Human Growth Hormone Market, By Country, 2018 - 2030 (USD Million)
  • Table 74 Latin America Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 75 Latin America Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 76 Latin America Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 77 Brazil Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 78 Brazil Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 79 Brazil Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 80 Mexico Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 81 Mexico Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 82 Mexico Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 83 Argentina Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 84 Argentina Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 85 Argentina Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 86 Middle East & Africa Human Growth Hormone Market, By Country, 2018 - 2030 (USD Million)
  • Table 87 Middle East & Africa Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 88 Middle East & Africa Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 89 Middle East & Africa Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 90 South Africa Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 91 South Africa Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 92 South Africa Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 93 Saudi Arabia Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 94 Saudi Arabia Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 95 Saudi Arabia Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 96 UAE Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 97 UAE Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 98 UAE Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 99 Kuwait Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 100 Kuwait Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 101 Kuwait Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Human Growth Hormone Market Segmentation
  • Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 10 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 11 Penetration & Growth Prospect Mapping
  • Fig. 12 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 13 Porter's Five Forces Analysis
  • Fig. 14 Human growth hormone market: Product outlook and key takeaways
  • Fig. 15 Human growth hormone market: Product movement analysis & market share 2022 & 2030
  • Fig. 16 Long-acting market, 2018 - 2030 (USD Million)
  • Fig. 17 Others market, 2018 - 2030 (USD Million)
  • Fig. 18 Human growth hormone market: Application outlook and key takeaways
  • Fig. 19 Human growth hormone market: Application movement analysis & market share 2022 & 2030
  • Fig. 20 Growth hormone deficiency market, 2018 - 2030 (USD Million)
  • Fig. 21 Adult growth hormone deficiency market, 2018 - 2030 (USD Million)
  • Fig. 22 Pediatric growth hormone deficiency market, 2018 - 2030 (USD Million)
  • Fig. 23 Turner syndrome market, 2018 - 2030 (USD Million)
  • Fig. 24 Idiopathic short stature market, 2018 - 2030 (USD Million)
  • Fig. 25 Prader-Willi syndrome market, 2018 - 2030 (USD Million)
  • Fig. 26 Small for gestational age market, 2018 - 2030 (USD Million)
  • Fig. 27 Other market, 2018 - 2030 (USD Million)
  • Fig. 28 Human growth hormone market: Distribution channel method outlook and key takeaways
  • Fig. 29 Human growth hormone market: Distribution channel method movement analysis & market share 2022 & 2030
  • Fig. 30 Hospital pharmacy market, 2018 - 2030 (USD Million)
  • Fig. 31 Retail pharmacy market, 2018 - 2030 (USD Million)
  • Fig. 32 Online pharmacy market, 2018 - 2030 (USD Million)
  • Fig. 33 Specialty pharmacy market, 2018 - 2030 (USD Million)
  • Fig. 34 Regional Marketplace: Key Takeaways
  • Fig. 35 Regional Outlook, 2022 & 2030
  • Fig. 36 Regional Market Dashboard
  • Fig. 37 Regional Market Place: Key Takeaways
  • Fig. 38 North America
  • Fig. 39 North America Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 40 U.S. Key Country Dynamics
  • Fig. 41 U.S. America Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 42 Canada Key Country Dynamics
  • Fig. 43 Canada Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 44 Europe Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 45 UK Key Country Dynamics
  • Fig. 46 UK Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 47 Germany Key Country Dynamics
  • Fig. 48 Germany Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 49 France Key Country Dynamics
  • Fig. 50 France Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 51 Italy Key Country Dynamics
  • Fig. 52 Italy Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 53 Spain Key Country Dynamics
  • Fig. 54 Spain Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 55 Sweden Key Country Dynamics
  • Fig. 56 Sweden Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 57 Norway Key Country Dynamics
  • Fig. 58 Norway Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 59 Denmark Key Country Dynamics
  • Fig. 60 Denmark Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 61 Russia Key Country Dynamics
  • Fig. 62 Russia Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 63 Turkey Key Country Dynamics
  • Fig. 64 Turkey Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 65 Asia Pacific America Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 66 Japan Key Country Dynamics
  • Fig. 67 Japan Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 68 China Key Country Dynamics
  • Fig. 69 China Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 70 India Key Country Dynamics
  • Fig. 71 India Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 72 Australia Key Country Dynamics
  • Fig. 73 Australia Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 74 Thailand Key Country Dynamics
  • Fig. 75 Thailand Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 76 South Korea Key Country Dynamics
  • Fig. 77 South Korea Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 78 Indonesia Key Country Dynamics
  • Fig. 79 Indonesia Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 80 Latin America Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 81 Brazil Key Country Dynamics
  • Fig. 82 Brazil Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 83 Mexico Key Country Dynamics
  • Fig. 84 Mexico Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 85 Argentina Key Country Dynamics
  • Fig. 86 Argentina Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 87 Middle East and Africa America Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 88 South Africa Key Country Dynamics
  • Fig. 89 South Africa Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 90 Saudi Arabia Key Country Dynamics
  • Fig. 91 Saudi Arabia Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 92 UAE Key Country Dynamics
  • Fig. 93 UAE Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 94 Kuwait Key Country Dynamics
  • Fig. 95 Kuwait Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 96 Nigeria Key Country Dynamics
  • Fig. 97 Nigeria Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 98 Strategy Mapping